Medicines manufacturing in the Czech Republic

„Generic and biosimilar drugs reduce health care costs and thanks to that, treatment is accessible to more patients who need it and can access it in an earlier stage of a disease.”

„We view generic drugs and biosimilars as very important for the securing of health care sustainability and the budget stability of health insurance companies. Generics and biosimilars allow us to increase the number of treated patients and provide better treatment accessibility.”

„Generics and biosimilars are an important pillar to ensure the availability of medicines. Especially recently, the importance of having sufficient diversity in supply chains to provide an alternative product in the event of a failure has become apparent.”